Cardiolipin-Based Nanoparticles Inhibit α-Synuclein Fibrilization.

Synucleinopathies are a group of neurodegenerative disorders characterized by structural aberrations in the protein alpha-synuclein (α-syn). In these disorders, α-syn accumulates and misfolds, contributing to the formation of intracellular inclusion…

Preview only. Read the full abstract at the source